Medicines, Medical Devices & Laboratory Tools

The thesis

Own the companies manufacturing medicines, medical devices and laboratory tools rather than healthcare insurers or care-delivery platforms. Drugmakers and medical-product suppliers have shown resilience during the technology pullback, offering exposure to treatment demand and research spending outside the crowded AI infrastructure trade. Commercial franchises anchor the basket, while pipeline execution, reimbursement pressure and laboratory spending remain important risks.